The rising prevalence of hepatitis c virus along with liver cancer is driving the Hepatitis C Testing Market says Fortune Business Insights in a report “Hepatitis C Testing Market Size, Share and Global Trend, By Technique (Immunoassays, Polymerase Chain Reaction (PCR), Others), By Test (Antibody Test, Genotype Tests, Viral Load Test), By End-User (Hospital-based Laboratories, Stand-alone Laboratories, Others), and Geography Forecast till 2026.” The rising number of government programs for spreading awareness about hepatitis c is likely to support the growth of the global hepatitis market.
Innovation In Hepatitis Testing System Will Give Quick Results
Hepatitis C is primarily caused by the hepatitis c virus, consisting of three types of hepatitis mainly named as hepatitis A, B, and C. Hepatitis C market on the basis of technique is segmented into immunoassays, polymerase chain reaction (PCR), others. On the basis of test the market is segmented into antibody test, genotype tests, viral load test. Acquisition of companies for the development of diagnostic is expected to encourage growth of the global hepatitis c testing market. For Instance, Access Bio Inc. and Atomo Diagnostics announced the development of the rapid diagnostic test (RDT) for screening for hepatitis C virus (HCV). Furthermore, increasing cases of liver cancer and high diagnosis rates for hepatitis c in emerging nations are likely to drive the global market for hepatitis c testing. In addition, the rising number of government programs for spreading awareness concerning hepatitis C testing is also a key factor contributing to the growth of the hepatitis C market. Hepatitis C testing has been made compulsory for organ donation in various regions, this factor is also likely to fuel demand and enable the growth of the hepatitis C testing market.
Top Key Players Covered:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Hepatitis C Testing market. Some of the companies operating the global Hepatitis C Testing market are;
- OraSure Technologies, Inc.
- Siemens Healthcare Private Limited
- Bio-Rad Laboratories, Inc.
- Bayer AG, QIAGEN
- Thermo Fisher Scientific Inc.
- Polymerase Chain Reaction (PCR)
- Antibody Test
- Genotype Tests
- Viral Load Test
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Gilead’s Launch of HepConnect to Boost Growth
Gilead Sciences launched their hepconnect, a billion-dollar initiative aimed to address the high prevalence of hepatitis C (HCV) infections. The statics of HCV has shown alarming rates. The launch is predicted to contribute considerable growth to the global hepatitis c testing market owing to Hepconnect which will ensure and fight HCV infections by testing the virus and giving appropriate care to the affected. Further new initiatives by key players to find innovative ways to test hepatitis and find a significant solution is driving the global hepatitis C testing market. For Instance, In April 2019, Access Bio Inc. and Atomo Diagnostics unveiled the development of the rapid diagnostic test (RDT) for screening for hepatitis C virus (HCV). Development in diagnostic test and initiatives by the key player are some of the factor fueling demand for hepatitis testing and thus subsequently boosting the global market.
Major Table of Content For Hepatitis C Testing Market:
- Executive Summary
- Market Dynamics
- Key Insights
- Global Hepatitis C Testing Market Analysis, Insights and Forecast
- North America Hepatitis C Testing Market Analysis, Insights and Forecast
Rising Awareness Of Advanced Products Will Contribute Growth In Asia Pacific
Geographically, the global hepatitis C testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Presently, North America, followed by Europe, leads the global market for hepatitis c testing. North America is predicted to dominate the global hepatitis C testing market during the forecast period due to the rising prevalence of hepatitis c in the region. Asia Pacific is projected to grow at a significant rate during the forecast period. Rising awareness of advanced products for hepatitis c testing in emerging nations is contributing growth for the hepatitis c testing market in the region. Further increasing population is also a reason fostering the growth of hepatitis C testing industry in the region. In Latin America the market is likely to grow at an outstanding CAGR, owing to the rising awareness of advanced products and increasing patient pool for hepatitis c testing.
Some of the major companies that are present in the global market are OraSure Technologies, Inc., Abbott, Siemens Healthcare Private Limited, Bio-Rad Laboratories, Inc., Bayer AG, QIAGEN, Thermo Fisher Scientific Inc., BioGenex, AccuQuick, and others.
More Trending Topics From Fortune Business [email protected]